Art

J-GLOBAL ID：201502214435894372   Reference number：15A1289182

Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data

選択的セロトニン再取り込み阻害剤療法と自殺傾向の間の関連:米国食品医薬品局有害事象報告システムデータの分析

Author (9)： UMETSU Ryogo (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  ABE Junko (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  ABE Junko (Medical Database Co., Ltd.) ,  UEDA Natsumi (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  KATO Yamato (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  MATSUI Toshinobu (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  NAKAYAMA Yoko (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  KINOSADA Yasutomi (United Graduate School of Drug Discovery and Medical Information Sciences, Gifu Univ.) ,  NAKAMURA Mitsuhiro (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.)
Material： Biological and Pharmaceutical Bulletin  (Biological & Pharmaceutical Bulletin)
Volume： 38  Issue： 11  Page： 1689-1699 (J-STAGE)  Publication year： 2015 
JST Material Number： S0989A  ISSN： 0918-6158  CODEN： BPBLEO  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： suicidality ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1289182&from=J-GLOBAL&jstjournalNo=S0989A") }}

JST classification (2)： Clinical psychiatry in general  (GR01030T) ,  Clinical application of psychotropic drugs  (GW03110J)

Reference (38)：

• 1) Lockhart P, Guthrie B. Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br. J. Gen. Pract., 61, e565-e572 (2011).
• 2) Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, Evans S, Gunnell D. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ, 330, 389 (2005).
• 3) Olfson M, Marcus MC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: A case control study. Arch. Gen. Psychiatry, 63, 865-872 (2006).
• 4) March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J, Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA, 292, 807-820 (2004).
• 5) Wijlaars LPMM, Nazareth I, Whitaker HJ, Evans SJW, Petersen I. Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis. BMJ Open, 3, e003247 (2013).

Terms in the title (6)： 選択的セロトニン再取り込み阻害剤 ,  療法 ,  自殺傾向 ,  米国食品医薬品局 ,  有害事象報告 ,  分析